Stay updated on Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe new screenshot shows only minor UI/formatting updates on the Study Details page, with no changes to core trial information (title, conditions, eligibility criteria, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check19 days agoNo Change Detected
- Check40 days agoChange DetectedAdded a government funding status notice and updated version to v3.2.0; removed the old v3.1.0 reference.SummaryDifference3%

- Check48 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a v3.1.0 release tag.SummaryDifference0.1%

- Check62 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; Back to Top was removed, indicating a minor UI change with no substantive content changes.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check76 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new medical topics related to colorectal cancer and specific compounds. Notably, the previous version's details about azacitidine and various antineoplastic agents have been removed.SummaryDifference3%

Stay in the know with updates to Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.